Program Leadership

Photo of George M. Abraham, MD, MPH, FACP, FIDSA

George M. Abraham, MD, MPH, FACP, FIDSA

Chief of Medicine

Dr. George M. Abraham is Chief of Medicine at Saint Vincent Hospital, Worcester, Massachusetts, a Professor of Medicine at the University of Massachusetts Medical School, and Adjunct Professor at the Massachusetts College of Pharmacy and Health Sciences (MCPHS). He is board certified in Internal Medicine and Infectious Disease.

He is the Immediate-Past President (2021-22) of the American College of Physicians (the largest internal medicine specialty organization in the world), having served as the Emeritus Chair of the Board of Governors and a Regent of the College prior. He served as the Governor of the Massachusetts Chapter of the American College of Physicians (ACP) from 2014-18 and as Chair of the Board of Governors from 2018-19. Recently, he was awarded a Mastership in the College and a Fellowship of the Royal College of Physicians, London (UK).

He is the Chair Emeritus of the Infectious Disease Board of the American Board of Internal Medicine, which is tasked with certifying all subspecialists in the field of infectious disease.

Dr. Abraham is also the Immediate-Past Chair of the Board of Registration (Licensing) in Medicine, Massachusetts (appointed by Governor Deval M. Patrick and reappointed by Governor Charles D. Baker). Prior to this, he has served as a Trustee of the Massachusetts Medical Society (owner of the New England Journal of Medicine), as President of the Worcester District Medical Society, as the Chief Medical Officer of the Central Massachusetts Independent Physician Association and Chair of the Board of Directors of the Health Foundation of Central Massachusetts.

He is a member of the Board of Directors of the Federation of State Medical Boards (FSMB) that oversees and coordinates with all the physician medical licensing boards in the US.

He has received several awards including the AOA Volunteer Faculty Award and the Outstanding Primary Care Educator Award of UMass Medical School; the Leadership Award of the MA chapter of the ACP; and the Phi Lambda Sigma honorary Membership, MCPHS, Worcester, Massachusetts, Saint Vincent Hospital Physician of the Year 2015, among others. Most recently, he was awarded the John H. Clarke Leadership Award by the Federation of State Medical Boards.

His research interests include hepatitis C and B disease, travel medicine and infection control, as well as medication safety and systems improvement. He has authored over 100 publications, abstracts and book chapters, and is an invited speaker at national and international meetings.

Dr. Abraham earned his medical degrees from the Christian Medical College, Ludhiana, India, completed his residency and chief residency at Saint Vincent Hospital, and received his master’s degree in public health from the Johns Hopkins Bloomberg School of Public Health.

Selected Bibliography (recent):

  1. Lal, A, Abraham GM. Utility of CD4 Cell Count and Viral Load Assay in Hospitalized Patients with Known HIV Infection: High Value Care Exercise. Infect Disord Drug Targets. DOI: 10.2174/1871526519666191011162018
  2. Sahu KK, Mishra AK, Lal A, Abraham GM. A double-edged sword: E-cigarettes, and other electronic nicotine delivery systems (ENDS). Internal and Emergency Medicine http://link.springer.com/article/10.1007/s11739-019-02203-3
  3. Gantzer HE, Fincher JW, Fox WE, Kane GC, Cooney TC, Abraham GM, Andrews R. Election 2020: Comparison of the American College of Physicians’ Vision for a Better US Health Care System with the Presidential Candidates’ Plans. doi:10.7326/M20-7089
  4. Tripathi K, Trivedi N, Abraham GM. Impact of Hepatitis C Remission on Glycemic Control in Patients with Type 2 Diabetes Mellitus: Primary Care Outpatient Experience. Journal of Community Hospital Internal Medicine Perspectives, 11:3, 354-356 https://doi.org/10.1080/20009666.2021.1886631
  5. Mishra AK, George AA, Sahu KK, Lal A, Abraham GM. Review of Clinical Profile, Risk Factors and Outcome in Patients with Tuberculosis and COVID-19. Acta Biomed 2021; Vol. 92, N. 1: e2021025 https:// DOI: 10.23750/abm.v92i1.10738
  6. Venkataraman SVA, George L, Sahu KK, Abraham GM. A 5-Year Retrospective Review of Raoultella Planticola Bacteriuria. Infection and Drug Resistance 2021:14 1989–2001
  7. Centor RM, Abraham G, Jena AB. The Importance of International Medical Graduates. Annals On Call November 01, 2021. DOI: 10.7326/A20-0024
  8. Nalluru SS, Piranavan, P, Narimiti, A, Abraham G. The Incidence and Economic Burden of Infection in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort Study. BMC Cancer (preprint). DOI: 10.21203/rs.3.rs-64420/v1
  9. Singh Y, Gogtay M, Yekula A, Tripathi K, Abraham G. Calculator for detection of colorectal adenomas by using artificial intelligence models in patients with chronic hepatitis C. World Journal of Gastroenterology 2022 (Accepted for publication). DOI: 10.1016/S0016-5085(22)63585-6
  10. Gogtay M, Singh Y, Varma N, Soni A, Subedi P, Sommer DB, Abraham GM, George SV. A case-control study of distinguishing between stroke mimics and true strokes. Journal of Community Hospital Internal Medicine Perspectives July 2022: Volume 12; Issue 4 DOI: 10.55729/2000-9666.1076
  11. Singh Y, Gogtay M, Gurung S, Trivedi N, Abraham GM. Assessment of Predictive Factors of Hepatic Steatosis Diagnosed by Vibration Controlled Transient Elastography (VCTE) in Chronic Hepatitis C Virus-Infected Patients. Journal of Community Hospital Internal Medicine Perspectives July 2022: Volume 12; Issue 4 DOI: 10.55729/2000-9666.1071
  12. Singh Y, Gogtay M, Yekula A, Tripathi K, Abraham G. Is hepatic steatosis individually a risk factor for detection of colorectal adenomas by using artificial intelligence models in patients with chronic hepatitis C. World Journal of Gastroenterology 2022 (Accepted for publication). DOI: 10.1016/S0168-8278(22)00842-X
  13. Mishra AK, Abraham BM, Sahu KK, George AA, Sargent JB, Kranis MJ, George SV, Abraham GM. Harms and Contributors of Leaving Against Medical Advice in Patients with Infective Endocarditis. J Patient Saf 2022;00: 00–00 DOI: 0.1097/PTS.0000000000001055

(Collaborative/National Task Force)

  1. Doherty R, Cooney TG, Mire RD, et al, for the Health and Public Policy Committee and Medical Practice and Quality Committee of the American College of Physicians. Envisioning a Better U.S. Health Care System for All: A Call to Action by the American College of Physicians. Ann Intern Med. 2020; 172: S3–S6. https://doi.org/10.7326/M19-2411
  2. Crowley R, Daniel H, Cooney TG, et al, for the Health and Public Policy Committee of the American College of Physicians. Envisioning a Better U.S. Health Care System for All: Coverage and Cost of Care. Ann Intern Med. 2020; 172:S7–S32. https://doi.org/10.7326/M19-2415
  3. Butkus R, Rapp K, Cooney TG, et al, for the Health and Public Policy Committee of the American College of Physicians. Envisioning a Better U.S. Health Care System for All: Reducing Barriers to Care and Addressing Social Determinants of Health. Ann Intern Med. 2020; 172:S50–S59. https://doi.org/10.7326/M19-2410
  4. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Miller M, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL for the Scientific Medical Policy Committee of the American College of Physicians. Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis of Treatment of COVID-19? Living Practice Points from the American College of Physicians (Version 2). https://www.acpjournals.org/doi/10.7326/M20-1998
  5. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Miller M, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL for the Scientific Medical Policy Committee of the American College of Physicians. Use of N95, Surgical, and Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points from the American College of Physicians. Living Practice Points from the American College of Physicians (Version 1). https://www.acpjournals.org/doi/10.7326/M20-3234
  6. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Miller M, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL for the Scientific Medical Policy Committee of the American College of Physicians. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points from the American College of Physicians (Version 1). https://www.acpjournals.org/doi/10.7326/M20-5831
  7. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Miller M, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL for the Scientific Medical Policy Committee of the American College of Physicians. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points from the American College of Physicians (Version 2).
  8. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Forciea MA, Abraham GM, Miller M, Obley AJ, Jokela JA, Humphrey LL for the Scientific Medical Policy Committee of the American College of Physicians. What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points from the American College of Physicians (Version 1). https://doi.org/10.7326/M20-7569
  9. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Miller M, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL for the Scientific Medical Policy Committee of the American College of Physicians. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points from the American College of Physicians (Version 2) DOI: 10.7326/L21-0607
  10. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Forciea MA, Abraham GM, Miller M, Obley AJ, Humphrey LL for the Scientific Medical Policy Committee of the American College of Physicians. What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 2) DOI: 10.7326/M21-3272